Included In This Lesson
Outline
What is the Generic Name
ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE
What is the Trade Name for ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE
Triumeq
What is the Indication for ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE
- 1 INDICATIONS AND USAGE TRIUMEQ and TRIUMEQ PD are indicated for the treatment of HIV-1 infection in adults and in pediatric patients weighing at least 10 kg. Limitations of Use: • TRIUMEQ and TRIUMEQ PD alone are not recommended in patients with resistance ‑ associated integrase substitutions or clinically suspected integrase strand transfer inhibitor (INSTI) resistance because the dose of dolutegravir in TRIUMEQ and TRIUMEQ PD is insufficient in these subpopulations. See full prescribing information for TIVICAY (dolutegravir). TRIUMEQ and TRIUMEQ PD are a combination of dolutegravir (integrase strand transfer inhibitor [INSTI]), abacavir, and lamivudine (both nucleoside analogue reverse transcriptase inhibitors) indicated for the treatment of HIV-1 infection in adults and in pediatric patients weighing at least 10 kg. ( 1 ) Limitations of Use: • TRIUMEQ and TRIUMEQ PD alone are not recommended in patients with resistance-associated integrase substitutions or clinically suspected INSTI resistance because the dose of dolutegravir in TRIUMEQ and TRIUMEQ PD is insufficient in these subpopulations. See the dolutegravir prescribing information. ( 1 )
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources